Clinical evaluation of Virechana Karma in Non-Alcoholic Fatty Liver Disease(NAFLD)
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Improvement will be assessed on the basis of Subjective parameters-
研究概览
简要总结
The study is Single arm clinical study to evaluate the efficacy of Virechana Karma in Non-Alcoholic Fatty liver disease(NAFLD). The study will be conducted at Gurukul Campus, Uttarakhand Ayurved University, Haridwar in 30 patients. The assessment will be done on the basis of Subjective and Objective parameters. The study will be conducted at OPD/IPD level of PG Department of Panchkarma. The result will be tabulated and statistically analyzed using appropriate tests.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 16.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Age 16 to 60 years.
- •2.Fatty liver grade1-
- •3.An individual fit for Virechana Karma.
排除标准
- •1.History of Liver transplantation.
- •3.Patients who consume alcohol.
- •4.Patients having uncontrolled diabetes, Hypothyroidism, Hypertension and other life-threatening diseases.
结局指标
主要结局
Improvement will be assessed on the basis of Subjective parameters-
时间窗: Outcome will be assessed at baseline,30th and 60th day
1.Fatigue
时间窗: Outcome will be assessed at baseline,30th and 60th day
2.Abdominal pain
时间窗: Outcome will be assessed at baseline,30th and 60th day
3.Nausea and Vomiting
时间窗: Outcome will be assessed at baseline,30th and 60th day
4.Abdominal distension
时间窗: Outcome will be assessed at baseline,30th and 60th day
5.Loss of appetite
时间窗: Outcome will be assessed at baseline,30th and 60th day
次要结局
- LFTs(Lipid Profile)
研究者
Anchal Choudhary
Gurukul Campus, Uttarakhand Ayurved University, Haridwar